Clinical trials sponsored by Shanghai Proton and Heavy Ion Center

Phase breakdown

Conditions studied

Recruiting trials led by Shanghai Proton and Heavy Ion Center

• A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction
  NCT05692674 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Female · 1 location
• Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer
  NCT05424159 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
  NCT05613452 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
  NCT05010343 · Phase: Phase 2 · Ages: 45 Years to 85 Years · Sex: Male · 1 location
• Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy
  NCT07135661 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Female · 1 location

Common questions

How many trials is Shanghai Proton and Heavy Ion Center recruiting for?

Shanghai Proton and Heavy Ion Center is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.